Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 14500219.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to evaluate the efficacy of percutaneous radiofrequency ablation of hepatic neuroendocrine metastases for symptomatic relief of neuroendocrine syndromes. Percutaneous radiofrequency ablation, a minimally invasive technique, is an effective and safe way to reduce systemic symptoms in patients with hepatic metastases from neuroendocrine neoplasms.
Medical subject headings
- Carcinoma, Neuroendocrine
- Catheter Ablation
- Liver Neoplasms
- Malignant Carcinoid Syndrome
- Pancreatic Neoplasms